Medtronic (MDT) Stock Price & Analysis

MDT$102.86—
Medical - DevicesLarge Cap
Compare
Market cap$127.84BEnterprise value—Revenue (TTM)$37.54BMarket positionTop 25%

Score

52
Neutral
Value
50
Quality
56
Growth
49

AI Analysis

Snapshot

Medtronic is a mixed profile at 52/100 — Value 50, Growth 49, Quality 56. Under the hood: P/E 25.1, plus revenue compounding ~5% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

50
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

49
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

56
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Medtronic Plc (MDT) last printed $102.86. Equity value is $127.84B. Trailing earnings multiple 25.15. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2017201820192020202120222023202420252026
$29.71B$29.95B$30.56B$28.91B$30.12B$31.69B$31.23B$32.36B$33.54B$36.36B

About

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Medtronic (MDT) Stock Price & Analysis

MDT price $102.86 —

Ticker
MDT
Price
$102.86
Change
—
Market cap
$127.84B
P/E
25.15
Forward P/E
17.21
Dividend yield
2.78%
Beta
0.57
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
52
Value
50
Quality
56
Growth
49

Stocklytics score rationale: value 50, quality 56, growth 49.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener